Kolaviron Isolated from Garcinia kola Seed Inhibits Snake Venom Phosphodiesterase Activity
DOI:
https://doi.org/10.4314/njbmb.v39i2.2Keywords:
Snake venom phosphodiesterase, Kolaviron, Toxic protein/enzymes, reducing agent , inhibition patternAbstract
Most of the snake venom toxic enzymes that induce severe pathological effects belong to the hydrolytic class, including phosphodiesterase (svPDE) and kolaviron (KV) from Garcinia kola seed (GKS) happens to be a potent inhibitor against this class of enzymes. This study demonstrated the inhibitory effect of KV against svPDE activity. KV, isolated through successive extraction methods from GKS, was validated via Liquid Chromatography-Mass Spectrometry (LC-MS). KV was assessed enzymatically for its ability to inhibit svPDE. About 1% KV was obtained from 50 g pulverized GKS following LC-MS spectra analysis. KV inhibited svPDE in a dose-dependent pattern with an IC50 value of 40 µg/mL. Lineweaver-Burk plot of initial velocity data of inhibition by KV revealed a non-competitive pattern with a Ki value of 22 µg/mL at 40 µg/mL of KV. The KM remained constant at 2.4 µg/mL, while Vmax changed from 10.6 µmol/min/mg to 3.7 µmol/min/mg in the presence of 40 µg/mL of KV. This study suggests that KV could act as a potential inhibitor capable of countering the toxic action of svPDE in a non-competitive manner and may be used in treating snakebite victims.
Downloads
References
Abubakar, A. Z., Adamu, A., Shehu, U. F., Mohammed, Z., Ibrahim, G., and Abubakar, M. S. (2020). Phospholipase A2 from Naja nigricollis and inhibitory activity of extracts from Commiphora africana (A. Rich.) Engl.(Burseraceae). Tropical Journal of Natural Product Research (TJNPR), 4(7), 286-291.
Baillie, G. S., Tejeda, G. S., and Kelly, M. P. (2019). Therapeutic targeting of 3′, 5′-cyclic nucleotide phosphodiesterases: inhibition and beyond. Nature Reviews Drug Discovery, 18(10), 770-796.
Bender, A. T. and Beavo, J. A. (2006). Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacological Reviews, 58(3), 488-520.
Bondarev, A. D., Attwood, M. M., Jonsson, J., Chubarev, V. N., Tarasov, V. V., Liu, W. and Schioth, H. B. (2022). Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules. Frontiers in Pharmacology, 13, 1057083.
Bickler, P.E. (2020). Amplification of snake venom toxicity by endogenous signaling pathways. Toxin, 12(2),68
Cotterill, P. J., Scheinmann, F. and Stenhouse, I. A (1978). Extractives from Guttiferae. Part 34. Kolaflavanone, a new biflavanone from the nuts of Garcinia kola Heckel. Applications of 13C nuclear magnetic resonance in elucidation of the structures of flavonoids. Journal of the Chemical Society Perkin Transactions, 1(6): 532 – 539.
Delhaye, S. and Bardoni, B. (2021). Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders. Molecular Psychiatry, 26(9), 4570-4582.
Ibrahim, N. M., Salama, W. H. and Hakim, A. E. E. (2016). Phosphodiesitrase activity of some Egyptian snake venoms: biochemical and immunological characteristics and effect on blood coagulation of phosphodiesterase enzyme from Naja nigricollis venom. Journal of Chemical and Pharmaceutical Research, 8(11): 160-170.
Mamillapalli, R., Haimovitz, R., Ohad, M. and Shinitzky, M. (1998). Enhancement and inhibition of snake venom phosphodiesterase activity by lysophospholipids. Federation of European Biochemical Societies (FEBS) Letters, 436(2), 256-258.
Mitra, J. and Bhattacharyya, D. (2014). Phosphodiesterase from Daboia russelli russelli venom: purification, partial characterization and inhibition of platelet aggregation. Toxicon, 88, 1-10.
Nichols, M. R. and Morimoto, B. H. (2000). Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins. Molecular Pharmacology, 57(4), 738-745.
Nok, A. J., Balogun, E., Lori, J. A. and Abubakar, M. S. (2002). Inhibition of Naja nigricolis venom acidic phospholipase A2 catalysed hydrolysis of ghost red blood cells by columbin. Journal of Enzyme Inhibition and Medicinal Chemistry, 17(1), 55-60.
Okafor, A. I., Ogban, N. N. and Odinigwe, A. A. (2022). Kolaviron alleviates haematological abnormalities and hepato-renal damage in Naja nigricollis nigricollis venom-treated rats. Toxicology Reports, 9, 1869-1876.
Okafor, A. I. and Onyike, E. (2021). Inhibition of key enzymes linked to snake venom induced local tissue damage by kolaviron. Journal of Basic and Clinical Physiology and Pharmacology, 32(6), 1121-1130.
Onasanwo, S. A., Singh, N., Olaleye, S. B. and Palit, G. (2011). Anti-ulcerogenic and proton pump (H+, K+ ATPase) inhibitory activity of Kolaviron from Garcinia kola Heckel in rodents. Indian Journal of Experimental Biology, 49(6): 461-468.
Salehi, B., Mishra, A. P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P. V. T., Martins, N. and Sharifi-Rad, J. (2018). Resveratrol: A double-edged sword in health benefits. Biomedicines, 6(3), 91.
Shah, Z. A., Abu-Izneid, T., Rauf, A., Rashid, U., Nizam, M., Muhammad, N. and Rengasamy, K.R.R. (2020). Phosphodiesterase 1 inhibition and molecular docking study of phytochemicals isolated from stem heartwood of Heterophragma adenophyllum Seem. South African Journal of Botany, 135, 274-279.
Tehara, S. K. and Keasling, J. D. (2003). Gene cloning, purification, and characterization of a phosphodiesterase from Delftia acidovorans. Applied and Environmental Microbiology, 69(1), 504-508.
Ullah, A., Ullah, K., Ali, H., Betzel, C. and ur Rehman, S. (2019). The sequence and a three-dimensional structural analysis reveal substrate specificity among snake venom phosphodiesterases. Toxins, 11(11), 625.
Uzair, B., Khan, B. A., Sharif, N., Shabbir, F. and Menaa, F. (2018). Phosphodiesterases (PDEs) from snake venoms: therapeutic applications. Protein and Peptide Letters, 25(7), 612-618.
Additional Files
Published
Issue
Section
Categories
License
Copyright (c) 2024 Azubuike I. Okafor (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
